7,557 press releases indexed under healthcare.
Om Uro and Eye Care, led by Dr. Neel Shah and Dr. Ritu Shah, now offers advanced urology and eye care services in Vadodara. The clinic addresses kidney stones, prostate disease, and comprehensive eye health.
Basel, 10 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The filing acceptance is based on positive results from the Phase III METEOROID study, which showed that Enspryng provided consistent, clinically meaningful improvements for people living with MOGAD. 1 This marks the second FDA Priority Review for Enspryng, following the one granted for thyroid eye disease (TED) in June 2026. The FDA is expected to make a decision on approval in MOGAD by 10 January 2027.
MKS Disability Services has expanded its in-home NDIS Disability Services Provider in Melbourne for people with disability across Melbourne. The team knows that each person [read full press release...]
Natura Pro Skin Tag Remover ingredients, bloodroot, Zincum Muriaticum, 2026 pricing, reviews and complaints, refund terms, customer support, FDA context, and key buyer considerations are examined for consumers researching the at-home formula.
As men's wellness remains a high-interest category in 2026, this Vapofil review explores the brand-stated seven-ingredient formula, exact label amounts, pricing, and how the supplement is positioned for circulation, hormonal balance, prostate health, and everyday vitality support-along with the key details buyers should verify before ordering.
If batch-level lab access, product variety, transparent pricing, and traceability are high on the buyer checklist, this Super Speciosa review examines why the brand may warrant a closer look in 2026-plus the product, policy, FDA, DEA, and local-law details consumers should verify before ordering.
As GLP-1 users explore what may come next in their body-composition journey, this NEOLISE Sculpt review examines the brand's tesamorelin positioning, who the program is marketed toward, pricing, provider evaluation, clinical evidence, and the practical questions buyers are weighing before deciding whether it fits their goals.
As more consumers explore provider-guided longevity programs in 2026, this NEOLISE Longevity review examines the brand's CJC-1295 + ipamorelin protocol, current pricing, prescription process, FDA status, and the factors buyers may want to compare before deciding whether the program fits their long-term wellness routine.
CAMBRIDGE, Mass., Sept. 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase...
For buyers drawn to a simpler, no-boil snoring-support option, this Snorelio review examines the brand-stated jaw-positioning design, current pricing, return terms, company details, and unresolved FDA and review-verification questions that could shape whether it fits their nighttime routine.
As more consumers explore provider-guided peptide options for recovery support in 2026, this NEOLISE Recovery review examines the brand-stated BPC-157/TB-500 protocol, current pricing, telehealth process, FDA compounding status, and the details buyers are comparing before deciding whether to request a clinical evaluation.
NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE AMERICAN: PMI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit,...